Growth Disorders Completed Phase 3 Trials for Somatotropin (DB00052)
Also known as: Growth Disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028940 (Growth Disorders) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00174421 | Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height | Treatment | |
| NCT00191074 | Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature | Treatment |